Medro Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: compounded semaglutide or tirzepatide with the regular price shown next to the first-month discount
Medro scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $199 a month, the same as the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Medro sells compounded semaglutide at $199 a month and compounded tirzepatide at $299, with a $99 discount auto-applied to the first plan, so the advertised $99 and $199 cover month one only. Plans renew at the regular price. It also sells microdose versions and brand-name GLP-1s when eligible, with free shipping and no membership. Medro Health Technologies, Inc. of San Francisco runs the site; an unnamed partner medical group prescribes and an unnamed pharmacy fills. It shows a LegitScript seal.
Is Medro legit?
Yes. Medro is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 6.9/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Medro promo or coupon code?
We know of no promo or coupon code for Medro. Its listed price is $199 a month. Coupon sites advertising "Medro discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Medro compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Medro
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Medro at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- What's included
- Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How Medro scores
Six columns, each one computed from something Medro has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.0/10$199/month is exactly the median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
5.0/10Where this seller first shows a price is not known, so sign-up is held at the midpoint.
Trust & Safety15%
6.0/10No pharmacy is named for its prescriptions. There is no confirmed price before the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
4.5/10The price covers the medication and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Medro
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Medro
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
Cancelling Medro
Taken from the terms Medro publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None; plans renew automatically until canceled
- Refund policy
- Fees are generally non-refundable once an order is processed, fulfilled, dispensed or shipped.
- Early-termination fee
- None
Medications Medro lists
Medro lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
"Flat $99/mo, down from $199/mo" with a $99-off first-plan code auto-applied; plans renew at regular pricing. Final price shown before checkout.
"Flat $199/mo, down from $299/mo" with the $99-off first-plan code; renews at regular pricing.
Check the price yourself before you pay
Every figure here comes from Medro's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, exactly the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- The monthly price includes the medication and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Medro
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Medro charges
Medro charges $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $299/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Medro's $199 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare Medro's cancellation terms with other sellers' cancellation and refund policies.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What Medro dispenses
Medro prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Medro tells you that it treats patients in all 50 states. We found no FDA warning letters issued to Medro. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Medro will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Medro bills your plan before you start.
It fits if
- you need access wherever you live
Our read
Medro lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Belle Health is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Medro scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $199 a month, the same as the $199 median among the sellers we compare.
Before you pay Medro
Starting at $199 a month. Check today's price, then start the intake.
Where Medro is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Medro sets more sellers in the same category beside Medro on price, states and what the price includes.
Frequently Asked Questions
How to check Medro yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
Every seller that ships to your state, side by side: Arizona, Delaware, Idaho, Indiana, Nevada, New Jersey, Oregon, Rhode Island and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Medro review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Medro's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.